A recent analysis published by the Lancet has predicted that yearly heat-related deaths could increase by 370 per cent by the 2050s worldwide if global temperatures rise by 2°C over pre-industrial levels.

Vulnerable populations across the world, which include the elderly and children, are now exposed to twice as many heatwave days due to climate change.

These projections are part of the latest edition of the Lancet Countdown on Health and Climate Change.

“Our health stocktake reveals that the growing hazards of climate change are costing lives and livelihoods worldwide today. Projections of a 2°C hotter world reveal a dangerous future, and are a grim reminder that the pace and scale of mitigation efforts seen so far have been woefully inadequate to safeguard people’s health and safety”, Marina Romanello, Executive Director of the Lancet Countdown at University College, London, said in a statement.

Watch:&nbsp;Nations voice their concerns about climate change | WION Climate Tracker

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/nations-voice-their-concerns-about-climate-change-wion-climate-tracker-640128/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

“With 1,337 tonnes of carbon dioxide still emitted every second, we aren’t reducing emissions anywhere near fast enough to keep climate hazards within the levels that our health systems can cope with,” the statement added.

The study represents the work of 114 experts from 52 research institutions and UN agencies, including the World Health Organization (WHO) and the World Meteorological Organisation (WMO).

<h2>Significance ahead of COP28 Summit</h2>

This report comes at a crucial time ahead of the climate summit COP28 that will be held in Dubai in less than a month. For the first time in the history of climate conferences, there is an entire day dedicated to health.

“There is still room for hope” Romanello added in the statement.

“The health focus at COP28 is the opportunity of our lifetime to secure commitments and action. If climate negotiations drive an equitable and rapid phase out of fossils fuels, accelerate mitigation, and support adaptation efforts for health, the ambitions of the Paris Agreement to limit global heating to 1.5 °C are still achievable, and a prosperous healthy future lies within reach,” the statement reads further.

<h2>Impact on health and economy</h2>

Even with the current global average heating of 1.14°C over the past decade, an analysis revealed that people, on average, faced 86 days of health-threatening high temperatures during 2018-2022.

Alarmingly, over 60 per cent of these occurrences were more than twice as likely due to man-made climate change.&nbsp;

The impact on health was evident, with an 85 per cent increase in heat-related deaths among individuals aged over 65 from 2013-2022, surpassing the expected 38 per cent increase based on unchanged temperatures since 1991-2000.

The economic ramifications were substantial, with the total value of losses from extreme weather events reaching an estimated $264 billion in 2022, marking a 23 per cent increase compared to 2010-2014.&nbsp;

<a href="https://www.wionews.com/world/china-records-522-celsius-temperature-in-arid-northwest-616575">Also read:&nbsp;China sees new July record of 52.2 Celsius temperature in arid northwest</a>

Heat exposure contributed to a staggering 490 billion potential labour hours lost globally in 2022, reflecting an almost 42 per cent surge from 1991-2000. Notably, income losses disproportionately affected the GDP of low-income (6.1 per cent) and middle-income countries (3.8 per cent). These escalating losses not only pose a threat to livelihoods but also curtail the ability to effectively cope with and recover from the consequences of climate change.

(With inputs from agencies)

A recent analysis published by the Lancet has predicted that yearly heat-related deaths could increase by 370 per cent by the 2050s worldwide if global temperatures rise by 2°C over pre-industrial levels.

A recent analysis published by the Lancet has predicted that yearly heat-related deaths could increase by 370 per cent by the 2050s worldwide if global temperatures rise by 2°C over pre-industrial levels. Vulnerable populations across the world, which include the elderly and children, are now exposed to twice as many heatwave days due to climate change. These projections are part of the latest edition of the Lancet Countdown on Health and Climate Change. “Our health stocktake reveals that the growing hazards of climate change are costing lives and livelihoods worldwide today. Projections of a 2°C hotter world reveal a dangerous future, and are a grim reminder that the pace and scale of mitigation efforts seen so far have been woefully inadequate to safeguard people’s health and safety”, Marina Romanello, Executive Director of the Lancet Countdown at University College, London, said in a statement. Watch: Nations voice their concerns about climate change | WION Climate Tracker × “With 1,337 tonnes of carbon dioxide still emitted every second, we aren’t reducing emissions anywhere near fast enough to keep climate hazards within the levels that our health systems can cope with,” the statement added. The study represents the work of 114 experts from 52 research institutions and UN agencies, including the World Health Organization (WHO) and the World Meteorological Organisation (WMO). Significance ahead of COP28 Summit This report comes at a crucial time ahead of the climate summit COP28 that will be held in Dubai in less than a month. For the first time in the history of climate conferences, there is an entire day dedicated to health. “There is still room for hope” Romanello added in the statement. “The health focus at COP28 is the opportunity of our lifetime to secure commitments and action. If climate negotiations drive an equitable and rapid phase out of fossils fuels, accelerate mitigation, and support adaptation efforts for health, the ambitions of the Paris Agreement to limit global heating to 1.5 °C are still achievable, and a prosperous healthy future lies within reach,” the statement reads further. Impact on health and economy Even with the current global average heating of 1.14°C over the past decade, an analysis revealed that people, on average, faced 86 days of health-threatening high temperatures during 2018-2022. Alarmingly, over 60 per cent of these occurrences were more than twice as likely due to man-made climate change. The impact on health was evident, with an 85 per cent increase in heat-related deaths among individuals aged over 65 from 2013-2022, surpassing the expected 38 per cent increase based on unchanged temperatures since 1991-2000. The economic ramifications were substantial, with the total value of losses from extreme weather events reaching an estimated $264 billion in 2022, marking a 23 per cent increase compared to 2010-2014. Also read: China sees new July record of 52.2 Celsius temperature in arid northwest Heat exposure contributed to a staggering 490 billion potential labour hours lost globally in 2022, reflecting an almost 42 per cent surge from 1991-2000. Notably, income losses disproportionately affected the GDP of low-income (6.1 per cent) and middle-income countries (3.8 per cent). These escalating losses not only pose a threat to livelihoods but also curtail the ability to effectively cope with and recover from the consequences of climate change. (With inputs from agencies)

Climate crisis: Heat-related deaths might rise 370% by 2050s, claims study

A new study has revealed that the number of adults living with diabetes worldwide will more than double by 2050, climbing to 1.3 billion from 529 million in 2021.

A new study has revealed that the number of adults living with diabetes worldwide will more than double by 2050, climbing to 1.3 billion from 529 million in 2021. The findings published in The Lancet and The Lancet Diabetes & Endocrinology journals have blamed rapidly rising obesity levels and widening health inequalities as the reason for the rapid rise. The paper added that no country will see a decline in age-standardised diabetes rates over the next 30 years. The scientists said Type-2 diabetes remained the most prevalent among the patient pool, accounting for 96 per cent of the cases. “Type 2 diabetes, which makes up the bulk of diabetes cases, is largely preventable and, in some cases, potentially reversible if identified and managed early in the disease course. However, all evidence indicates that diabetes prevalence is increasing worldwide, primarily due to a rise in obesity caused by multiple factors,” wrote the research authors. In diabetes, the patient's body is unable to control blood sugar levels. Currently, one in 10 adults globally is affected by diabetes and it led to 6.7 million deaths in 2021 alone. According to the researchers, the pandemic amplified diabetes inequality globally. People who had diabetes were twice as likely to contract COVID-19 and die, compared to those without diabetes. Racism and economic inequality The study also mentioned racism and economic inequality as an impediment to controlling the spread of diabetes globally. “Racist policies such as residential segregation affect where people live, their access to sufficient and healthy food and healthcare services. This cascade of widening diabetes inequity leads to substantial gaps in care and clinical outcomes for people from historically disenfranchised racial and ethnic groups, including Black, Hispanic and Indigenous people," said co-author Leonard Egede of the Medical College of Wisconsin. WATCH | Diabetes cases to double to 1.3 billion by 2050 – study × Indians suffering from diabetes Earlier this month, another report published in the Lancet stated that India, the world's most populous nation, is home to 101 million people with diabetes, while 136 million people are dealing with prediabetes. The Indian Council of Medical Research (ICMR) and the Indian Ministry of Health and Family Welfare jointly financed the country's largest epidemiological research on diabetes and chronic noncommunicable diseases (NCDs). Also read | Over 101 million people diabetic in India, Goa leads the list: Study The western state of Goa had the most significant prevalence of diabetes, at 26.4 per cent, while the northern state of Uttar Pradesh had the lowest, at 4.8 per cent. (With inputs from agencies) WATCH WION LIVE HERE:

More than 1.3 billion people globally to have diabetes by 2050: Study

Official US documents have disclosed that a popular anti-stroke medicine may have used fictitious data while concealing research on its fatal effects. In 2009, the acclaimed British medical journal, The Lancet, published a prime story on rivaroxaban, a blood thinner medicine, which showed that the treatment was safe and efficient. But recently, the same journal warned of defaults in the trial data and claimed to initiate an investigation over it.

Lancet opens probe into ‘unreliable’ anti-stroke medicine

A recent alarming&nbsp;discovery has revealed that toxic air particles have been found in the lungs, brains, and livers of even unborn children.&nbsp;

The study was published in the journal Lancet Planetary Health. The study was conducted in Scotland and Belgium with non-smoking mothers in places with low air pollution.&nbsp;

A total of 36 foetuses were examined in Scotland as a part of the study, with pregnancies between seven and 20 weeks.&nbsp;

<a href="https://www.wionews.com/world/asteroid-that-wiped-out-dinosaurs-also-triggered-global-tsunami-waves-says-study-522647">Also read |&nbsp;Asteroid that wiped out dinosaurs also triggered massive tsunami waves, says study</a>

Thousands of black carbon particles were found in cubic millimetres of tissue, which were inhaled by the mothers during their pregnancy and then passed through the bloodstream to the foetus.&nbsp;

Dirty air particles are already known as potential reasons for increased miscarriages, premature births, and low birth weights of children. The particles are made of tiny soot particles from the burning of fossil fuels from homes, vehicles, and even factories.&nbsp;

A professor from the University of Aberdeen in Scotland said that this research shows how black carbon nanoparticles enter the first and second-trimester placenta, but also enter into the developing organs of the foetus.

<a href="https://www.wionews.com/science/report-uks-drax-renewable-energy-power-station-cuts-down-primary-forest-in-canada-522193">Also read |&nbsp;UK’s Drax renewable energy power station cuts down primary forest in Canada, says report</a>

Prof Tim Nawrot, who co-led the study, said that "air quality regulation should recognise this [air pollution] transfer during gestation and act to protect the most susceptible stages of human development," the Guardian reported.&nbsp;

The professor said that governments are responsible for cutting air pollution and that people should avoid going when roads are busy.&nbsp;

A comprehensive global review was conducted in 2019 which found that air pollution might be damaging organs and every cell in the body.&nbsp;

Over 90 per cent of the world's population resides in areas where air pollution is above the WHO's guidelines, causing millions of deaths.&nbsp;

(With inputs from agencies)

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

A recent alarming discovery has revealed that toxic air particles have been found in the lungs, brains, and livers of even unborn children. The study was published in the journal Lancet Planetary Health.

A recent alarming discovery has revealed that toxic air particles have been found in the lungs, brains, and livers of even unborn children. The study was published in the journal Lancet Planetary Health. The study was conducted in Scotland and Belgium with non-smoking mothers in places with low air pollution. A total of 36 foetuses were examined in Scotland as a part of the study, with pregnancies between seven and 20 weeks. Also read | Asteroid that wiped out dinosaurs also triggered massive tsunami waves, says study Thousands of black carbon particles were found in cubic millimetres of tissue, which were inhaled by the mothers during their pregnancy and then passed through the bloodstream to the foetus. Dirty air particles are already known as potential reasons for increased miscarriages, premature births, and low birth weights of children. The particles are made of tiny soot particles from the burning of fossil fuels from homes, vehicles, and even factories. A professor from the University of Aberdeen in Scotland said that this research shows how black carbon nanoparticles enter the first and second-trimester placenta, but also enter into the developing organs of the foetus. Also read | UK’s Drax renewable energy power station cuts down primary forest in Canada, says report Prof Tim Nawrot, who co-led the study, said that "air quality regulation should recognise this [air pollution] transfer during gestation and act to protect the most susceptible stages of human development," the Guardian reported. The professor said that governments are responsible for cutting air pollution and that people should avoid going when roads are busy. A comprehensive global review was conducted in 2019 which found that air pollution might be damaging organs and every cell in the body. Over 90 per cent of the world's population resides in areas where air pollution is above the WHO's guidelines, causing millions of deaths. (With inputs from agencies) WATCH WION LIVE HERE

New study alarmingly finds toxic air particles in lungs and brains of unborn babies

Globally, one in four or 27 per cent of women are victims of violence at the hands of an intimate partner before the age of 50, according to a study published in The Lancet.

The study, carried out by researchers from McGill University and the World Health Organization (WHO) on more than 2 million women in 161 countries, showed that one in seven women (or 13 per cent) experienced intimate partner violence.

Also read |&nbsp;<a href="https://www.wionews.com/world/hell-breaks-loose-as-lancet-describes-women-as-bodies-with-vaginas-416804">Hell breaks loose as Lancet describes women as 'bodies with vaginas'</a>

In addition, the analysis points to high levels of violence against young women. Around 24 per cent of those between the ages of 15 and 19 reported that they had experienced domestic violence in their lifetime.

Researchers from McGill University and the WHO noted that, while the numbers are alarming, the true scale of violence is likely much higher, given that the study was based on self-reported experiences.

Women may be reluctant to report their experiences due to the stigmatised nature of the issue, they explained.

Also read |&nbsp;<a href="https://www.wionews.com/science/transplantation-of-organs-from-deceased-covid-19-patients-is-possible-heres-how-464932" hreflang="en">Transplantation of organs from deceased COVID-19 patients is safe and possible. Here's how</a>

"Intimate partner violence against women - which includes physical and sexual violence by husbands, boyfriends, and other partners - is highly prevalent globally," noted Mathieu Maheu-Giroux, a professor at McGill University.

According to the researchers, there were regional differences between high- and low-income countries, with a lower prevalence of cases reported both in terms of violence over the past year and in a lifetime.

Africa, South Asia, and parts of South America had the highest lifetime prevalence of violence among women aged 15 to 49. Among the regions, with the lowest lifetime domestic violence estimates, Central Asia and Central Europe ranked highest.

Watch |&nbsp;High levels of violence against women in South Africa

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/high-levels-of-violence-against-women-in-south-africa-449259/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

Women in North America, Europe, and the Asia Pacific experienced intimate partner violence at a rate of about 5 per cent in the past year. In some areas of Africa, this number is as high as 15 per cent to 30 per cent.

"Overall, our research shows that governments are not on track to meet global targets to eliminate violence against women and girls. An important takeaway is that even in some high-income countries the prevalence of intimate partner violence is relatively high, which calls for investment in prevention at local and global levels," said Maheu-Giroux.

Researchers explained that the <a href="https://www.wionews.com/topics/coronavirus">COVID-19</a> pandemic may have further compounded the problem worldwide. They said it was urgent to strengthen the public health response to intimate partner violence and ensure that the issues are addressed in the rebuilding efforts following COVID-19.

(With inputs from agencies)

Globally, one in four or 27 per cent of women are victims of violence at the hands of an intimate partner before the age of 50, according to a study published in The Lancet.

Globally, one in four or 27 per cent of women are victims of violence at the hands of an intimate partner before the age of 50, according to a study published in The Lancet. The study, carried out by researchers from McGill University and the World Health Organization (WHO) on more than 2 million women in 161 countries, showed that one in seven women (or 13 per cent) experienced intimate partner violence. Also read | Hell breaks loose as Lancet describes women as 'bodies with vaginas' In addition, the analysis points to high levels of violence against young women. Around 24 per cent of those between the ages of 15 and 19 reported that they had experienced domestic violence in their lifetime. Researchers from McGill University and the WHO noted that, while the numbers are alarming, the true scale of violence is likely much higher, given that the study was based on self-reported experiences. Women may be reluctant to report their experiences due to the stigmatised nature of the issue, they explained. Also read | Transplantation of organs from deceased COVID-19 patients is safe and possible. Here's how "Intimate partner violence against women - which includes physical and sexual violence by husbands, boyfriends, and other partners - is highly prevalent globally," noted Mathieu Maheu-Giroux, a professor at McGill University. According to the researchers, there were regional differences between high- and low-income countries, with a lower prevalence of cases reported both in terms of violence over the past year and in a lifetime. Africa, South Asia, and parts of South America had the highest lifetime prevalence of violence among women aged 15 to 49. Among the regions, with the lowest lifetime domestic violence estimates, Central Asia and Central Europe ranked highest. Watch | High levels of violence against women in South Africa Women in North America, Europe, and the Asia Pacific experienced intimate partner violence at a rate of about 5 per cent in the past year. In some areas of Africa, this number is as high as 15 per cent to 30 per cent. "Overall, our research shows that governments are not on track to meet global targets to eliminate violence against women and girls. An important takeaway is that even in some high-income countries the prevalence of intimate partner violence is relatively high, which calls for investment in prevention at local and global levels," said Maheu-Giroux. Researchers explained that the COVID-19 pandemic may have further compounded the problem worldwide. They said it was urgent to strengthen the public health response to intimate partner violence and ensure that the issues are addressed in the rebuilding efforts following COVID-19. (With inputs from agencies)

1 in 4 women experienced physical or sexual abuse at the hands of their partner: Lancet

Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to a study published in The Lancet journal.

The researchers from University College London (UCL) in the UK noted that if the antibody levels carry on dropping at this rate, there are concerns that the protective effects of the vaccines may also begin to wear off, particularly against new variants.

However, they said, how soon that might happen cannot be predicted yet.

The UCL Virus Watch study also found that antibody levels are substantially higher following two doses of the Pfizer vaccine than after two shots of the AstraZeneca preventive, known as Covishield in India.

Antibody levels were also much higher in vaccinated people than those with prior SARS-CoV-2 infection, they said.

"The levels of antibody following both doses of either the AstraZeneca or Pfizer vaccine were initially very high, which is likely to be an important part of why they are so protective against severe COVID-19," said Madhumita Shrotri from UCL Institute of Health Informatics.

"However, we found these levels dropped substantially over two to three months," Shrotri said in a statement.

The findings based on data from over 600 people aged 18 and above were consistent across all groups of people regardless of age, chronic illnesses or sex, according to the researchers.

The authors highlight that although the clinical implications of waning antibody levels are not yet clear, some decline was expected and current research shows that vaccines remain effective against severe disease.

For Pfizer, antibody levels reduced from a median of 7506 Units per millilitre (U/mL) at 2141 days, to 3320 U/mL at 70 or more days.

For the AstraZeneca vaccine, antibody levels reduced from a median of 1201 U/mL at 020 days to 190 U/mL at 70 or more days, over a five-fold reduction.

"When we are thinking about who should be prioritised for booster doses our data suggests that those vaccinated earliest, particularly with the AstraZeneca vaccine, are likely to now have the lowest antibody levels," said Professor Rob Aldridge from UCL Institute of Health Informatics.

The findings support recommendations that clinically vulnerable adults, those aged 70 years or over, and all residents of care homes for older adults should be prioritised for booster doses, the researchers said.

In addition, those who were vaccinated with the AstraZeneca vaccine are likely to have much lower antibody levels than those vaccinated with the Pfizer vaccine, they noted.

"This may also need to be considered when deciding who should be prioritised when boosters are rolled out," Aldridge said in the statement.

The team acknowledged certain limitations in the data, including a small sample size for some groups.

The researchers noted that each individual only contributed one sample, so they cannot yet confirm how quickly antibody levels drop for each individual, or whether these would continue to drop or reach a stable level over the next few months.

They also noted that different people will have different levels of immunity depending on the virus neutralising ability of their antibodies as well as their T-cell responses.

"Even when measurable antibody levels are low, there is likely to be continuing immune memory that could offer long-term protection," the authors of the study noted.

They said further research will be important to establish if there is an antibody level threshold needed for protection against severe disease.

Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to a study published in The Lancet journal.

Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to a study published in The Lancet journal. The researchers from University College London (UCL) in the UK noted that if the antibody levels carry on dropping at this rate, there are concerns that the protective effects of the vaccines may also begin to wear off, particularly against new variants. However, they said, how soon that might happen cannot be predicted yet. The UCL Virus Watch study also found that antibody levels are substantially higher following two doses of the Pfizer vaccine than after two shots of the AstraZeneca preventive, known as Covishield in India. Antibody levels were also much higher in vaccinated people than those with prior SARS-CoV-2 infection, they said. "The levels of antibody following both doses of either the AstraZeneca or Pfizer vaccine were initially very high, which is likely to be an important part of why they are so protective against severe COVID-19," said Madhumita Shrotri from UCL Institute of Health Informatics. "However, we found these levels dropped substantially over two to three months," Shrotri said in a statement. The findings based on data from over 600 people aged 18 and above were consistent across all groups of people regardless of age, chronic illnesses or sex, according to the researchers. The authors highlight that although the clinical implications of waning antibody levels are not yet clear, some decline was expected and current research shows that vaccines remain effective against severe disease. For Pfizer, antibody levels reduced from a median of 7506 Units per millilitre (U/mL) at 2141 days, to 3320 U/mL at 70 or more days. For the AstraZeneca vaccine, antibody levels reduced from a median of 1201 U/mL at 020 days to 190 U/mL at 70 or more days, over a five-fold reduction. "When we are thinking about who should be prioritised for booster doses our data suggests that those vaccinated earliest, particularly with the AstraZeneca vaccine, are likely to now have the lowest antibody levels," said Professor Rob Aldridge from UCL Institute of Health Informatics. The findings support recommendations that clinically vulnerable adults, those aged 70 years or over, and all residents of care homes for older adults should be prioritised for booster doses, the researchers said. In addition, those who were vaccinated with the AstraZeneca vaccine are likely to have much lower antibody levels than those vaccinated with the Pfizer vaccine, they noted. "This may also need to be considered when deciding who should be prioritised when boosters are rolled out," Aldridge said in the statement. The team acknowledged certain limitations in the data, including a small sample size for some groups. The researchers noted that each individual only contributed one sample, so they cannot yet confirm how quickly antibody levels drop for each individual, or whether these would continue to drop or reach a stable level over the next few months. They also noted that different people will have different levels of immunity depending on the virus neutralising ability of their antibodies as well as their T-cell responses. "Even when measurable antibody levels are low, there is likely to be continuing immune memory that could offer long-term protection," the authors of the study noted. They said further research will be important to establish if there is an antibody level threshold needed for protection against severe disease.

Pfizer, AstraZeneca vaccine antibody levels may decline after 2-3 months: Lancet study

Physical punishment of children is not effective in preventing child behaviour problems or promoting positive outcomes, according to a substantial narrative review.

The study predicts that punishments such as spanking increases in behaviour problems and other negative consequences over time. 
&nbsp; 
The Lancet jouurnal published a study by an international group of academics, including a researcher from The University of Texas in Austin.

The research evaluated 69 studies into corporal punishment conducted over the past 20 years. 
&nbsp; 
According to the United Nations Children's Fund (UNICEF), almost 300 million, or three-quarters, of the world's two- to four-year-old children are subjected to psychological abuse, physical punishment, or both by their caregivers at home. 
&nbsp; 
Sixty-two countries have banned the practice, which is increasingly seen as a form of violence. 
&nbsp; 
The consistency of these findings indicates that physical punishment is harmful to children and that policy remedies are warranted. 
&nbsp; 
The researchers looked at studies that involved physical punishment, such as spanking, and ruled out any practices that would be considered child abuse. 
&nbsp; 
The researchers discovered plenty of data to back up a UN statement from the Committee on the Rights of the Child, which urged that countries stop using all forms of physical punishment on children. 
&nbsp; 
UNICEF is urging governments to take immediate action and support measures such as developing well-coordinated national action plans, changing adult behaviours, limiting access to firearms and other weapons, and educating children, parents, teachers, and community members to recognise and report violence in all of its forms. 
&nbsp; 
(With inputs from agencies)

Physical punishment of children is not effective in preventing child behaviour problems or promoting positive outcomes, according to a substantial narrative review.

Physical punishment of children is not effective in preventing child behaviour problems or promoting positive outcomes, according to a substantial narrative review. The study predicts that punishments such as spanking increases in behaviour problems and other negative consequences over time. The Lancet jouurnal published a study by an international group of academics, including a researcher from The University of Texas in Austin. The research evaluated 69 studies into corporal punishment conducted over the past 20 years. According to the United Nations Children's Fund (UNICEF), almost 300 million, or three-quarters, of the world's two- to four-year-old children are subjected to psychological abuse, physical punishment, or both by their caregivers at home. Sixty-two countries have banned the practice, which is increasingly seen as a form of violence. The consistency of these findings indicates that physical punishment is harmful to children and that policy remedies are warranted. The researchers looked at studies that involved physical punishment, such as spanking, and ruled out any practices that would be considered child abuse. The researchers discovered plenty of data to back up a UN statement from the Committee on the Rights of the Child, which urged that countries stop using all forms of physical punishment on children. UNICEF is urging governments to take immediate action and support measures such as developing well-coordinated national action plans, changing adult behaviours, limiting access to firearms and other weapons, and educating children, parents, teachers, and community members to recognise and report violence in all of its forms. (With inputs from agencies)

Spanking harmful to children, worsens their behaviour: Lancet study

According to an observational study published in The Lancet Respiratory Medicine journal, a past COVID-19 infection does not completely protect young people from reinfection, and vaccination is still necessary to boost immune response and reduce disease transmission.

Study: Past COVID-19 infection does not fully protect against reinfection

The study of patients in London hospitals is consistent with emerging evidence that this lineage is more transmissible than the original COVID-19 strain.

UK Covid variant doesn’t lead to severe illness, death: The Lancet

COVID-19 patients may experience more severe symptoms the second time they are infected, according to research released Tuesday confirming it is possible to catch the potentially deadly disease more than once.

Study: COVID-19 reinfection casts doubt on virus immunity

A British COVID-19 test known as DnaNudge that gives results in just over an hour and which requires no laboratory was accurate in almost all cases, an academic review in the Lancet has found.

Faster testing could allow more people to return to work or permit testing on entry to hospital, thus slowing a second spike in coronavirus infections.

The new test, based on the design of a DNA test developed by a professor at Imperial College London, received approval for clinical use by the Medicines and Healthcare Products Regulatory Agency (MHRA) at the end of April after successful trials.

In a study in The Lancet Microbe, the test was found to have an average sensitivity – the ability to correctly identify those with COVID-19 – of 94.4% and a specificity – correctly identifying those without the disease – of 100%.

"These results suggest that the CovidNudge test, which can be performed at a patient’s bedside without the need to handle any sample material, has comparable accuracy to standard laboratory testing," Professor Graham Cooke, lead author of the study from the Department of Infectious Disease at Imperial College London, said.

The Lancet paper described the test, which requires one nostril swab, as "a sensitive, specific, and rapid point of care test for the presence of SARS-CoV-2 without laboratory handling or sample pre-processing".

Health Secretary Matt Hancock told LBC radio that Britain was rolling out the tests across hospitals.

"The critical thing in terms of usefulness is that the machine doesn`t need to be in a lab - it is about the size of a shoebox - therefore you can put one, say, in an A&amp;E (accident and emergency) department and they can know whether people coming in have got the coronavirus or not," Hancock said.

Hancock said the machines could also be deployed at other locations such as schools.

Each box can run one test at a time so could process about 16 tests per day, said a spokeswoman for the company that produces the tests.

A British COVID-19 test known as DnaNudge that gives results in just over an hour and which requires no laboratory was accurate in almost all cases, an academic review in the Lancet has found.

A British COVID-19 test known as DnaNudge that gives results in just over an hour and which requires no laboratory was accurate in almost all cases, an academic review in the Lancet has found. Faster testing could allow more people to return to work or permit testing on entry to hospital, thus slowing a second spike in coronavirus infections. The new test, based on the design of a DNA test developed by a professor at Imperial College London, received approval for clinical use by the Medicines and Healthcare Products Regulatory Agency (MHRA) at the end of April after successful trials. In a study in The Lancet Microbe, the test was found to have an average sensitivity – the ability to correctly identify those with COVID-19 – of 94.4% and a specificity – correctly identifying those without the disease – of 100%. "These results suggest that the CovidNudge test, which can be performed at a patient’s bedside without the need to handle any sample material, has comparable accuracy to standard laboratory testing," Professor Graham Cooke, lead author of the study from the Department of Infectious Disease at Imperial College London, said. The Lancet paper described the test, which requires one nostril swab, as "a sensitive, specific, and rapid point of care test for the presence of SARS-CoV-2 without laboratory handling or sample pre-processing". Health Secretary Matt Hancock told LBC radio that Britain was rolling out the tests across hospitals. "The critical thing in terms of usefulness is that the machine doesn`t need to be in a lab - it is about the size of a shoebox - therefore you can put one, say, in an A&E (accident and emergency) department and they can know whether people coming in have got the coronavirus or not," Hancock said. Hancock said the machines could also be deployed at other locations such as schools. Each box can run one test at a time so could process about 16 tests per day, said a spokeswoman for the company that produces the tests.

90-minute British DnaNudge COVID-19 test is 94.4% accurate, Lancet study finds

The debate is raging again. This time more than hundred scientists have questioned the authenticity of the much-hyped Lancet study. After the Lancet report, the World Health Organisation(WHO) had decided to suspend HCQ trials.

The debate is raging again. This time more than hundred scientists have questioned the authenticity of the much-hyped Lancet study. After the Lancet report, the World Health Organisation(WHO) had decided to suspend HCQ trials. The study had said the drug increased the risk of death. Now, The Lancet medical journal is itself concerned about the findings. Hydroxychloroquine was called a miracle drug and then a potential killer. What changed the verdict was The Lancet study. It claimed HCQ led to a higher risk of death and caused an irregular heartbeat. Soon, the drug's fame evaporated. The WHO suspended HCQ trials. Now, more than hundred scientists have questioned The Lancet study that called the drug dangerous. The Lancet medical journal has also alerted its readers. It is like the retraction of an incorrectly made comment and now serious scientific questions have been raised. Rightly put it's an expression of concern. The journal is now commissioning an independent audit of the data but the scientists want the WHO to carry out the checks. The Lancet study involved 96,000 COVID-19 patients spread across six continents. It involved patients from as many as 671 hospitals with 15,000 patients given doses of HCQ. The study found patients were at a greater risk of dying. They were also at a higher risk of developing abnormal heart rhythm. Now the question is: what made scientists doubt The Lancet study? The haste with which it was conducted analysing data, writing the paper and peer reviews -- all completed in five weeks much faster than usual. The authors have refused to identify any of the hospitals that contributed to patient data or name the countries where they were located. A data scientist has even called the study fabrication of data. Moreover, one of the authors is also the founder of Surgisphere which is a Chicago-based medical data analytics company. The study entirely relied on the data provided by the firm. Now, the affiliation has come under the scanner. The Lancet medical journal had to issue corrections after they got the death toll wrong. However, the WHO acted on this report and suspended the study on HCQ. India strongly opposed the suspension of trials. The Indian council of medical research(ICMR) has consistently backed the use of HCQ. ICMR studies have shown the positive effect of HCQ as a preventive drug. In a recent study, ICMR found that HCQ with personal protective equipment together cut COVID-19 risk by 80 per cent. Essentially, ICMR findings are contrary to The Lancet study. Studies in India found no side-effects other than nausea, vomiting and occasional palpitation. The drug has been in use for nearly 100 years in various avatars. It is also used for some other diseases such as lupus, rheumatoid arthritis and type-2 diabetes. The drug's uses and dangers are well-known. As ICMR said right dosage and monitoring should do the trick. but, let's place our trust in the scientific community to tell us more.

Is hydroxychloroquine a 'miracle' drug or a death pill?

A group consisting of 140 scientists and physicians has spoken out against a study published in The Lancet that found an association between the use of the drug hydroxychloroquine

Lancet's HCQ study comes under scanner

lancet-study

Lancet Study, News on Lancet Study, stories on Lancet Study, articles on Lancet Study, Lancet Study stories at Wion, Lancet Study news, Lancet Study latest news

lancet study